Evotec has achieved the second milestone in its research collaboration with Boehringer Ingelheim. Under the terms of the drug discovery contract, Evotec will receive a milestone payment from Boehringer for the identification of a number of lead series for a priority receptor target. Further projects within the collaboration are progressing and are on track to achieve additional project milestones for which Evotec is entitled to additional payments. The contract also provides substantial long-ter...